PRINCETON, N.J. & BOSTON--(BUSINESS WIRE)--Caliber Therapeutics, Inc. announced today a partnership with DSM Biomedical, a division of Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, for the development of a novel drug delivery balloon catheter that can be used to treat vascular diseases such as atherosclerosis.
